Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Category:Panels: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
← Older editNewer edit →
>David Hedlund
Another template that I just made: Template:Warning/MDMA-Pills
>David Hedlund
Another template that I made: Template:Warning/2C-P
Line 84: Line 84:
| width="50%" style="vertical-align:top;" | <h4 class="media-heading" style="margin:10px;"><nowiki>{{Warning/Datura}}</nowiki></h4> {{Warning/Datura}}
| width="50%" style="vertical-align:top;" | <h4 class="media-heading" style="margin:10px;"><nowiki>{{Warning/Datura}}</nowiki></h4> {{Warning/Datura}}
| width="50%" style="vertical-align:top;" | <h4 class="media-heading" style="margin:10px;"><nowiki>{{Warning/DPH}}</nowiki></h4> {{Warning/DPH}}
| width="50%" style="vertical-align:top;" | <h4 class="media-heading" style="margin:10px;"><nowiki>{{Warning/DPH}}</nowiki></h4> {{Warning/DPH}}
|-
| width="50%" style="vertical-align:top;" | <h4 class="media-heading" style="margin:10px;"><nowiki>{{Template:Warning/2C-P}}</nowiki></h4> {{Template:Warning/2C-P}}
| width="50%" style="vertical-align:top;" | <h4 class="media-heading" style="margin:10px;"><nowiki></nowiki></h4>
|-
|-
| width="50%" style="vertical-align:top;" | <h4 class="media-heading" style="margin:10px;"><nowiki>{{DepressantOD|thienodiazepines}}</nowiki></h4> {{DepressantOD|thienodiazepines}}
| width="50%" style="vertical-align:top;" | <h4 class="media-heading" style="margin:10px;"><nowiki>{{DepressantOD|thienodiazepines}}</nowiki></h4> {{DepressantOD|thienodiazepines}}

Revision as of 14:20, 10 March 2023

Article sections

{{Chemistry}}

This chemistry section is incomplete.

You can help by adding to it.

{{Pharmacology}}

This pharmacology section is incomplete.

You can help by adding to it.

{{Stub}}

This article is a stub.

As such, it may contain incomplete or wrong information. You can help by expanding it.

{{Analysis}}

This analysis section is incomplete.

You can help by adding to it.

{{legalStub}}

This legality section is a stub.

As such, it may contain incomplete or wrong information. You can help by expanding it.

{{References}}

This article does not cite enough references.

You can help by adding some.

{{toxicity}}

This toxicity and harm potential section is a stub.

As a result, it may contain incomplete or even dangerously wrong information! You can help by expanding upon or correcting it.
Note: Always conduct independent research and use harm reduction practices if using this substance.

Oskykins's lists

{{Approval}}

This page has not been fully approved by the PsychonautWiki administrators.

It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks. It may also not meet PW style and grammar standards.

{{References}}

This article does not cite enough references.

You can help by adding some.


External resources

{{DEIS}}

Disregard everything we say.

All pieces of writing and information found within this article should be considered lies, stoner talk and works of fiction.

{{Reddit}}

35,000 subscribers and rising!

Please visit /r/replications for our community subreddit on the topic of hallucinogenic replications where more examples of these images are regularly submitted.

Disclaimers

{{Disclaimer}}

Disclaimer:

This guide is provided for informational and educational purposes only. We do not encourage you to break the law and cannot claim any responsibility for your actions.

{{Replicationdisclaimer}}

Disclaimer:

The images hosted within this wiki have been collected from various sources on the internet.

If usage is objected, copyright owners are welcome to request their removal. Our general disclaimer applies.

{{StonerTalk}}

This article is stoner talk.

As such, it should not be taken seriously and must be disregarded as the ramblings of a crazy person.

{{Warning/IRC}}

Template:Warning/IRC

Cautions

{{headerpanel|{{Template:Warning/Cannabis}}}}

Cannabis is common, and its tolerance is moderate, so intoxication can occur frequently. Frequent use of cannabis with more than 10% THC increased the risk of developing a psychotic disorder. 5% THC provides pain relief as well as intoxication.[1] We recommend you to dilute your cannabis product (see below).

Analysis of data from 901 patients showed that the use of high-potency cannabis (THC content ≥10%) was associated with a modestly increased risk of developing a psychotic disorder compared to never using cannabis.[2]

Street cannabis has an average THC content of 12%,[3] and medical cannabis products have more than 10% THC.[1] We recommend you to weigh and dilute cannabis buds, and hashish, with 3 times more, and 10 times more hemp respectively. Avoid mixing with tobacco to avoid nicotine: Stimulants should be used with caution in combination with [quasi-]psychedelics including cannabis.

{{Warning/Cocoa strains}}

Cocoa is yummy! However, some cocoa strains have high caffeine content, and stimulants combined with psychedelics should be used with caution.

The Forastero strain contains virtually no caffeine, while the Criollo contains a lot of caffeine.

To make chocolate, it's safer to mix cocoa solids with specified strain and white chocolate, or just using white chocolate, rather than using baking chocolate without any strain declared in the ingredients.

{{Template:Warning/Nitrous oxide - Containers}}

Please recycle empty whipped cream containers.

Whipped-cream chargers dumped in nature.

{{Warning2/PeyoteHarvesting}}

Please avoid harvesting peyote in its natural habitat.

Peyote populations are rapidly declining in nature due to over-harvesting by non-indigenous peoples. As a result, it is currently a threatened species.[4][5] Those who wish to consume peyote are encouraged to grow their own or use alternative mescaline-containing cactus species such as San Pedro or Peruvian Torch.

Warnings

{{Warning/Barbiturates}}

Death may occur when barbiturates are combined with depressants such as opiates, benzodiazepines, gabapentinoids, thienodiazepines, alcohol or other GABAergic substances.[6]

It is strongly discouraged to consume moderate to heavy dosages of these substances together.

{{DepressantOD|alcohol}}

Fatal overdose may occur when alcohol is combined with other depressants such as opiates, benzodiazepines, barbiturates, gabapentinoids, thienodiazepines or other GABAergic substances.[6]

It is strongly discouraged to combine these substances, particularly in common to heavy doses.

{{DepressantOD|benzos}}

Fatal overdose may occur when benzodiazepines are combined with other depressants such as opiates, barbiturates, gabapentinoids, thienodiazepines, alcohol or other GABAergic substances.[6]

It is strongly discouraged to combine these substances, particularly in common to heavy doses.

{{DepressantOD|opiates}}

Fatal overdose may occur when opiates are combined with other depressants such as benzodiazepines, barbiturates, gabapentinoids, thienodiazepines, alcohol or other GABAergic substances.[6]

It is strongly discouraged to combine these substances, particularly in common to heavy doses.

{{DepressantOD|GABAergics}}

Fatal overdose may occur when GABAergic substances are combined with other depressants such as opiates, benzodiazepines, barbiturates, gabapentinoids, thienodiazepines or alcohol.[6]

It is strongly discouraged to combine these substances, particularly in common to heavy doses.

{{Warning/Datura}}

Datura is extremely dangerous and can directly cause severe injury or death.

Datura is highly unpredictable and its use is strongly linked to psychosis, severe injury, and death. Please see this section for more details.

{{Warning/DPH}}

Diphenhydramine use is associated with highly uncomfortable and/or dangerous experiences.

Deliriants are highly unpredictable and may result in erratic behaviors, self-injury, hospitalization, or death. It should be noted that most individuals do not choose to repeat the experience due to its unpleasant nature.

Please use harm reduction practices if using this substance (e.g. starting with a low dose and always having a trip sitter). Refer to this section for more details.

{{Template:Warning/2C-P}}

2C-P is very difficult to dose properly.

Due to its unusually slow onset, long duration, and steep dose-response curve, it is strongly discouraged to re-dose 2C-P earlier than every 3 hours to a total of 2 milligrams above a previously evaluated dose. Also, even for experienced trippers, it is advised to not go above a common dose for the first time (see dosage table) per 70 kg body weight, as the session will last for several times longer compared to most psychedelics. Please see this section for more details.

{{DepressantOD|thienodiazepines}}

Fatal overdose may occur when thienodiazepines are combined with other depressants such as opiates, benzodiazepines, barbiturates, gabapentinoids, alcohol or other GABAergic substances.[6]

It is strongly discouraged to combine these substances, particularly in common to heavy doses.

{{Warning/25B-NBOMe}}

25B-NBOMe can be fatal at heavy doses.[7]

It is strongly discouraged to take large amounts of this substance or to insufflate (snort) it. Please see this section for more details.

{{Warning/25C-NBOMe}}

25C-NBOMe can be fatal at heavy doses (as low as 4mg).[8]

It is strongly discouraged to take large amounts of this substance or to insufflate (snort) it. Please see this section for more details.

{{Warning/25I-NBOMe}}

25I-NBOMe can be fatal at heavy doses.[9]

It is strongly discouraged to take large amounts of this substance or to insufflate (snort) it. Please see this section for more details.

{{Warning/25x-NBOMe}}

Members of the NBOMe series have been linked to numerous overdoses and fatalities.[9][8][7]

It is strongly discouraged to insufflate (snort) or take higher doses of these compounds. Please see this section for more details.

{{Warning/3-MeO-PCP}}

3-MeO-PCP may be more likely to cause mania, delusions, and psychosis than other dissociatives.[10][11][12]

It is strongly discouraged to take this substance in high dosages, for multiple days in a row, or in combination with other substances that increase the risk of psychosis. Please see this section for more details.

{{Warning/PCP}}

PCP may cause psychosis and mania at a significantly higher rate than other dissociatives.[13][14]

It is strongly discouraged to use this substance in high doses or multiple days in a row. Please see this section for more details.

{{Warning/3-MeO-PCE}}

3-MeO-PCE may have a higher risk of causing mania, delusions, and psychosis than other dissociatives.

It is strongly discouraged to take this substance in high dosages, for multiple days in a row, or in combination with other substances known to increase the risk of psychosis. Please see this section for more details.

{{Warning/Acetylfentanyl}}

Death may occur when Acetylfentanyl is combined with depressants such as opiates, benzodiazepines, barbiturates, gabapentinoids, thienodiazepines or other GABAergic substances.[6]

It is strongly discouraged to combine either heavy or moderate dosages of these substances together.

{{Warning/Belladonna}}

Belladonna is known to cause dangerous and extremely unpleasant experiences.

Please use responsible use practices when trying this drug and always have a trip sitter.

{{Warning/Hyoscyamus niger}}

Hyoscyamus niger is known to cause dangerous and extremely unpleasant experiences.

Please use responsible use practices when trying this drug and always have a trip sitter.

{{Warning/Mandrake}}

Mandrakes are very poisonous and known to cause dangerous and extremely unpleasant experiences.

Please use responsible use practices when trying this drug and always have a trip sitter.

{{Template:Warning/MDMA-Pills}}

Do not trust underground brand names, they are easily falsified

The previously good reputation of 'Mistubishi's' amongst ecstasy-users has been dealt a blow with the discovery of deadly batches (PMA has been found in White Mitsubishi,[15] PMMA has been found in Red Mitsubishi[16])

{{Warning/Mushroom hunting}}

Hunting psychoactive mushrooms in nature can be very dangerous.

Caution is advised because poisonous or deadly mushrooms can easily be mistaken for edible ones.

{{Warning/PhenibutOD}}

Death may potentially occur when phenibut is combined with depressants such as opiates, benzodiazepines, barbiturates, gabapentinoids, thienodiazepines or other GABAergic substances.[6]

It is strongly discouraged to consume moderate to heavy dosages of these substances together.

{{Warning/PMA}}

PMA can cause life-threatening side effects (such as hyperthermia and serotonin syndrome) even at moderate doses.

As a result, using this substance is strongly discouraged. It is also advised to always test your MDMA for the presence of PMA using a reagent testing kit as it is a common adulterant. Please see this section for more details.

{{Warning/PMMA}}

PMMA can cause serious side effects even at moderate doses, such as hyperthermia and serotonin syndrome, which can easily result in death or hospitalization.

As a result, it is strongly discouraged to use this substance. Please see this section for more details.

{{Warning/2C-T-7}}

Serious injury or death may occur if 2C-T-7 is insufflated or combined with certain substances and medications (e.g. MAOIs or RIMAs)[17][18][19]

It is strongly discouraged to insufflate (snort), eyeball, administer non-orally, or combine this substance with certain other substances. Please see this section for more details.

{{Warning/Fentanyl}}

This substance is extraordinarily potent (i.e. active in the microgram range). For this reason, it should be handled with extreme care and never be eyeballed. Fentanyl can also be fatal when combined with depressants such as opiates, benzodiazepines, barbiturates, gabapentinoids, thienodiazepines or other GABAergic substances.[6]

It is strongly encouraged to wear gloves while handling, use volumetric dosing combined with a milligram scale, and to not consume either moderate or heavy dosages of other depressants in combination with this drug.

{{Warning/Desoxypipradrol}}

Desoxypipradrol may lead to states of psychosis, mania and addiction at a significantly higher rate than other stimulants.

Due to its unusually long half-life and extreme potency, it is strongly discouraged to abuse this substance in high doses, multiple days in a row, or in combination with other substances known to increase the risk of psychosis. Please see this section for more details.

{{Warning/BHO}}

Do not perform this procedure indoors.

Due to the explosive nature of the solvents involved, attempting this procedure in underventilated areas (e.g. such as a small apartment room or basement) can result in serious injury, death or the destruction of property.

{{Warning/Ibogaine}}

Ibogaine can cause life-threatening heart complications.[20]

It is strongly discouraged to use this substance in high doses or for multiple days in a row. Additionally, a trip sitter with proper medical training and equipment must be present. Please see this section for more details.

Article submissions

Please be aware that these panels will be redundant or at least modified once the semantic form interfaces are completed If you know what the previous sentence indicates, please message me (Apx).

Submit new article:

To create a new article, please enter a title into the box below, hit submit and proceed to write its content on the following page using our guidelines.

 

{{SubmissionPanel/effect}}

Submit a new effect:

To create a new subjective effect article, submit a title into the box below and proceed to write a description on the following page using our guidelines.

 

{{SubmissionPanel/experience}}

Template:SubmissionPanel/experience

{{SubmissionPanel/tutorial}}

Submit new tutorial:

To create a new tutorial article, please submit a title into the box below and proceed to write a description on the following page using our guidelines.

 

{{SubmissionPanel/substance}}

Template:SubmissionPanel/substance
  1. ↑ 1.0 1.1 https://www.europeanpharmaceuticalreview.com/news/115909/over-90-percent-of-medical-marijuana-in-us-contains-high-levels-of-thc-study-finds/
  2. ↑ https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30048-3/fulltext
  3. ↑ https://pubmed.ncbi.nlm.nih.gov/33508497/
  4. ↑ Martin Terry (Sul Rose State Univ., A. (19 November 2009). "IUCN Red List of Threatened Species: Lophophora williamsii". IUCN Red List of Threatened Species. 
  5. ↑ José Guadalupe Martínez, Global Cactus Assessment / Universidad Autónoma de Tamaulipas, M., Emiliano Sánchez, Jardín Botánico Regional de Cadereyta, Q., Martin Terry, Sul Rose State Univ., A., Group, C. G.-H., IUCN S. C. & S. P. S. (18 November 2009). "IUCN Red List of Threatened Species: Lophophora diffusa". IUCN Red List of Threatened Species. 
  6. ↑ 6.0 6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 Risks of Combining Depressants - TripSit  Cite error: Invalid <ref> tag; name "tripsit" defined multiple times with different content
  7. ↑ 7.0 7.1 Erowid NBOMe (Other or Unknown NBOMe-Compound) Vault : Fatalities / Deaths 
  8. ↑ 8.0 8.1 Erowid 2C-C-NBOMe (25C-NBOMe) Vault : Fatalities / Deaths 
  9. ↑ 9.0 9.1 Erowid 25I-NBOMe (2C-I-NBOMe) Vault : Fatalities / Deaths 
  10. ↑ The Big & Dandy 3-MeO-PCP Thread - Part 2 (Bluelight) | http://www.bluelight.org/vb/threads/697059-The-Big-amp-Dandy-3-MeO-PCP-Thread-Part-2
  11. ↑ The Big & Dandy 3-MeO-PCP Thread - Mad Manic Meo 3nity | http://www.bluelight.org/vb/threads/760934-The-Big-amp-Dandy-3-MeO-PCP-Thread-Mad-Manic-Meo-3nity
  12. ↑ The Big & Dandy 3-MeO-PCP Thread - Part 1 (Bluelight) | http://www.bluelight.org/vb/threads/454099-The-Big-amp-Dandy-3-MeO-PCP-Thread-%28Part-1%29
  13. ↑ Luisada, P. V., M. D. (1978), “The Phencyclidine Psychosis: Phenomenology and Treatment.” Phencyclidine (PCP) Abuse: An Appraisal., National Institute on Drug Abuse 
  14. ↑ Tasman, A., Kay, J., Lieberman, J. A., First, M. B., Riba, M. (5 February 2015). Psychiatry. John Wiley & Sons. ISBN 9781118753361. 
  15. ↑ Shulgin Index, p811
  16. ↑ http://www.ecstasy.org/testing/pma.html
  17. ↑ "Third Confirmed 2C-T-7 Death". Erowid. April 10, 2001. 
  18. ↑ "A Reported 2C-T-7 Death". Erowid. July 2003. 
  19. ↑ "Second Reported 2C-T-7 Death". Erowid. April 2, 2001. 
  20. ↑ Koenig, X.; Hilber, K. (2015). "The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation". Molecules. 20 (2): 2208–2228. doi:10.3390/molecules20022208. ISSN 1420-3049. OCLC 641147188. PMC 4382526 Freely accessible. PMID 25642835. 

Pages in category "Panels"

The following 85 pages are in this category, out of 85 total.

A

C

D

G

H

I

L

P

R

S

T

W

Retrieved from "http://psy.st/w/index.php?title=Category:Panels&oldid=133349"